Sinha Vikas's Form 4 filing
Verona Pharma plc (VRNA) · filed May 1, 2025
- Accession no.
- 0001104659-25-043644
- Filed
- May 1, 2025
- Trade date
- Apr 29, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $178.4K. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001104659-25-051979 (May 22, 2025). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sinha VikasCIK 0001337845 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 29, 2025 | Ordinary Shares | MOption exerciseAcquired | +15,048 | $1.70 | +$25,581.6 | 89,488 | Direct | |
| Apr 29, 2025 | Ordinary Shares | SSaleDisposed | −15,048 | $8.92 | −$134,228.16 | 74,440 | Direct | |
| Apr 29, 2025 | Ordinary Shares | MOption exerciseAcquired | +4,952 | $0.50 | +$2,476 | 79,392 | Direct | |
| Apr 29, 2025 | Ordinary Shares | SSaleDisposed | −4,952 | $8.92 | −$44,171.84 | 74,440 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 29, 2025 | Ordinary Shares | MOption exerciseDisposed | −15,048 | $0.00 | $0 | 80,952 | Direct | |
| Apr 29, 2025 | Ordinary Shares | MOption exerciseDisposed | −4,952 | $0.00 | $0 | 195,048 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.